Patent · US Active

Biomedical materials

US10532114B2 · kind B2 · utility

0Cited by
6References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 27, 2017
Grant dateJan 14, 2020
Priority date
Expiry dateNov 14, 2037

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A synthetic calcium phosphate-based biomedical material comprising gadolinium. The material may comprises a compound having the general chemical formula: Ca10−yGdy(PO4)6−x(SiO4)x(OH)2−c+y where 0<x<1.3 and 0<y<1.3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.